A cough lasting more than three weeks could signal underlying health issues. Know possible causes, red flags, and when medical attention becomes essential.
Public Health Wales data breaks down which viruses are circulating in Wales ...
A chest pain is not always a sign of a heart attack, and can be a sign of several other conditions. Understanding this can help you to address the issue.
The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for brensocatib, branded as ...
UK MHRA grants marketing authorisation to Insmed Netherlands’ brensocatib to treat patients 12 years and older with non-cystic fibrosis bronchiectasis: United Kingdom Tuesday, F ...
The Punch on MSN
Cold meals raise food poisoning risk — Nutritionists
Nutrition experts have stated that eating cold food increases the risk of food poisoning and bacterial contamination, advising individuals to consume their meals while they are still warm to aid ...
Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...
Tired of that lingering cough? This surprising option may do the trick.
More than 80% of those treated with TREMFYA® were in clinical remission and more than 50% were in endoscopic remission at Week 140 of the QUASAR long-term extension ...
A 91-year-old man was admitted to the hospital with weight loss, dyspnea, and eosinophilia. An anteroposterior chest radiograph obtained 2 months earlier showed bibasilar patchy opacities. A ...
Brensocatib is the first medicine of its kind to be approved in the UK for preventing flare‑ups in NCFB. It works by blocking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results